FI92463B - Menetelmä sterolirakkuloiden valmistamiseksi ja yhdisteen sulkemiseksi niiden sisään - Google Patents

Menetelmä sterolirakkuloiden valmistamiseksi ja yhdisteen sulkemiseksi niiden sisään

Info

Publication number
FI92463B
FI92463B FI865021A FI865021A FI92463B FI 92463 B FI92463 B FI 92463B FI 865021 A FI865021 A FI 865021A FI 865021 A FI865021 A FI 865021A FI 92463 B FI92463 B FI 92463B
Authority
FI
Finland
Prior art keywords
bladders
sterol
containment
compound
preparation
Prior art date
Application number
FI865021A
Other languages
English (en)
Swedish (sv)
Other versions
FI865021A (fi
FI92463C (fi
FI865021A0 (fi
Inventor
Andrew Stuart Janoff
Mircea Constantine Popescu
Alan Lee Weiner
Lois E Bolcsak
Paul A Tremblay
Christine E Swenson
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/721,630 external-priority patent/US4721612A/en
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of FI865021A publication Critical patent/FI865021A/fi
Publication of FI865021A0 publication Critical patent/FI865021A0/fi
Application granted granted Critical
Publication of FI92463B publication Critical patent/FI92463B/fi
Publication of FI92463C publication Critical patent/FI92463C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Seal Device For Vehicle (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI865021A 1985-04-10 1986-12-10 Menetelmä sterolirakkuloiden valmistamiseksi ja yhdisteen sulkemiseksi niiden sisään FI92463C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US06/721,630 US4721612A (en) 1984-04-12 1985-04-10 Steroidal liposomes
US72163085 1985-04-10
US06/773,429 US4891208A (en) 1985-04-10 1985-09-10 Steroidal liposomes
US77342985 1985-09-10
US8501983 1985-10-10
PCT/US1985/001983 WO1986005977A1 (en) 1985-04-10 1985-10-10 Steroidal liposomes

Publications (4)

Publication Number Publication Date
FI865021A FI865021A (fi) 1986-12-10
FI865021A0 FI865021A0 (fi) 1986-12-10
FI92463B true FI92463B (fi) 1994-08-15
FI92463C FI92463C (fi) 1994-11-25

Family

ID=27110456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865021A FI92463C (fi) 1985-04-10 1986-12-10 Menetelmä sterolirakkuloiden valmistamiseksi ja yhdisteen sulkemiseksi niiden sisään

Country Status (16)

Country Link
US (1) US4891208A (fi)
EP (1) EP0222771A4 (fi)
JP (1) JPH0798741B2 (fi)
KR (1) KR890001882B1 (fi)
AU (2) AU596953B2 (fi)
CA (1) CA1262334A (fi)
DK (1) DK591086A (fi)
ES (2) ES8700933A1 (fi)
FI (1) FI92463C (fi)
HU (1) HU203205B (fi)
IE (1) IE66709B1 (fi)
IL (1) IL76600A (fi)
NO (1) NO173213C (fi)
NZ (1) NZ213601A (fi)
PT (1) PT81242B (fi)
WO (1) WO1986005977A1 (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231112A (en) * 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
JPH0761940B2 (ja) * 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
AU631377B2 (en) * 1988-08-25 1992-11-26 Liposome Company, Inc., The Affinity associated vaccine
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
US5055303A (en) * 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
JPH06507372A (ja) * 1991-05-16 1994-08-25 ベスター，インコーポレイテッド 薬剤の投与方法
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US5643600A (en) * 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
DE4131878A1 (de) * 1991-09-25 1993-04-01 Henkel Kgaa Verfahren zur herstellung von liposomen
AU6365894A (en) * 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Fluorocarbon compositions containing a visible or fluorescent label
JPH09502700A (ja) * 1993-04-02 1997-03-18 ザ リポソーム カンパニー、インコーポレーテッド リポソームの製造方法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5468224A (en) * 1993-11-30 1995-11-21 Souryal; Tarek O. Methods of color coding injectable medications
JPH09510432A (ja) * 1993-12-15 1997-10-21 マイクロパック インコーポレイテッド アボカド油不鹸化物を含む脂質小胞
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
US5670163A (en) * 1994-06-20 1997-09-23 Kv Pharmaceuticals Company Long acting GI and esophageal protectant
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5554380A (en) * 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
AU706267B2 (en) * 1994-11-30 1999-06-10 Supergen, Inc. Phosphocholine drug derivatives
US5739271A (en) * 1995-06-07 1998-04-14 Gen-Probe Incorporated Thiocationic lipids
US5711964A (en) * 1995-06-07 1998-01-27 United States Of America Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D
US5759519A (en) * 1995-06-07 1998-06-02 Gen-Probe Incorporated Method for the intracellular delivery of biomolecules using thiocationic lipids
US5851548A (en) * 1995-06-07 1998-12-22 Gen-Probe Incorporated Liposomes containing cationic lipids and vitamin D
US5756352A (en) * 1995-06-07 1998-05-26 Gen-Probe Incorporated Thiocationic lipid-nucleic acid conjugates
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine
JP2002514183A (ja) * 1996-09-17 2002-05-14 スーパージェン・インコーポレーテッド リン脂質薬剤誘導体
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
US7169410B1 (en) * 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
MXPA03007455A (es) * 2001-02-21 2004-07-30 Basf Ag Metodo y produccion de acido d-pantotenico y las sales de este como adyuvante en productos alimenticios para animales.
US7858117B2 (en) * 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
HU226519B1 (en) * 2002-11-26 2009-03-30 Istvan Dr Horvath Artificial blood made of hemoglobin encapsulated in membrane
WO2005063212A1 (en) * 2003-12-31 2005-07-14 Amorepacific Corporation Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
US20050266067A1 (en) * 2004-03-02 2005-12-01 Shiladitya Sengupta Nanocell drug delivery system
WO2006099445A2 (en) * 2005-03-14 2006-09-21 Massachusetts Institute Of Technology Nanocells for diagnosis and treatment of diseases and disorders
KR101172066B1 (ko) 2005-09-30 2012-08-10 (주)아모레퍼시픽 스티그마스테릴 헤미숙시네이트를 포함한 지질-기반 약물전달체 및 이를 함유하는 피부 외용제 조성물
US20100068264A1 (en) * 2006-07-12 2010-03-18 University Of South Florida Niosome-hydrogel drug delivery system
US20080317768A1 (en) * 2007-06-21 2008-12-25 Boeing Company Bioconjugated nanoparticles
US10688026B2 (en) 2009-04-27 2020-06-23 Premier Dental Products Company Buffered microencapsulated compositions and methods
US9814657B2 (en) * 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
CN103857387B (zh) 2011-06-02 2017-03-15 加利福尼亚大学董事会 膜包封的纳米颗粒及使用方法
US20170000875A1 (en) * 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
US9522114B1 (en) 2014-03-27 2016-12-20 University Of South Florida Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin
CN118078755A (zh) * 2024-04-19 2024-05-28 赣州市人民医院 一种单链双亲小分子/维生素d3甾醇脂质体及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3932657A (en) * 1973-11-12 1976-01-13 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome encapsulation of chelating agents
DE2404047A1 (de) * 1974-01-29 1975-08-14 Henkel & Cie Gmbh Hautpflege- und hautschutzmittel mit einem gehalt an haut-feuchthaltemitteln
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
US4040784A (en) * 1976-08-23 1977-08-09 Deshmukh Arvind D Method for checking the accuracy of a test, using a serum-soluble cholesterol compound
US4183847A (en) * 1976-08-23 1980-01-15 Deshmukh Arvind D Enzymatically hydrolyzable, serum-soluble cholesterol compounds and method for their preparation
US4042330A (en) * 1976-08-23 1977-08-16 Deshmukh Arvind D In a method for checking the accuracy of a test using an enzymatically hydrolyzable, serum-soluble cholesterol compound
DE2860862D1 (en) * 1977-10-13 1981-10-29 Siegfried Ag Imidazolylethylene-oxyalkyloxy derivatives and their thio analogues, methods for their preparation and pharmaceutical compositions containing them
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4298594A (en) * 1978-04-14 1981-11-03 Arthur D. Little, Inc. Xenobiotic delivery vehicles, method of forming them and method of using them
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
GR73668B (fi) * 1978-11-21 1984-03-28 Hoffmann La Roche
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4617161A (en) * 1983-09-06 1986-10-14 Baxter Travenol Laboratories, Inc. Method of manufacture for a dialyzer having improved side ports
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes

Also Published As

Publication number Publication date
AU4434589A (en) 1990-05-17
ES547326A0 (es) 1986-11-16
AU609647B2 (en) 1991-05-02
DK591086D0 (da) 1986-12-09
KR870700347A (ko) 1987-12-28
IL76600A (en) 1992-12-01
PT81242B (pt) 1987-10-20
JPH0798741B2 (ja) 1995-10-25
EP0222771A4 (en) 1988-06-08
US4891208A (en) 1990-01-02
CA1262334C (en) 1989-10-17
PT81242A (en) 1985-11-01
FI865021A (fi) 1986-12-10
FI92463C (fi) 1994-11-25
CA1262334A (en) 1989-10-17
JPS62502464A (ja) 1987-09-24
AU596953B2 (en) 1990-05-24
EP0222771A1 (en) 1987-05-27
ES8801085A1 (es) 1988-01-01
ES8700933A1 (es) 1986-11-16
KR890001882B1 (ko) 1989-05-29
ES553808A0 (es) 1988-01-01
NO173213B (no) 1993-08-09
HUT42322A (en) 1987-07-28
DK591086A (da) 1986-12-09
NO864960L (no) 1986-12-09
FI865021A0 (fi) 1986-12-10
IL76600A0 (en) 1986-02-28
NZ213601A (en) 1990-03-27
HU203205B (en) 1991-06-28
NO173213C (no) 1993-11-17
IE66709B1 (en) 1996-01-24
AU4952885A (en) 1986-11-05
WO1986005977A1 (en) 1986-10-23
IE852336L (en) 1986-10-10

Similar Documents

Publication Publication Date Title
FI92463B (fi) Menetelmä sterolirakkuloiden valmistamiseksi ja yhdisteen sulkemiseksi niiden sisään
PL261574A2 (en) Photopolymerizing compound and photopolymerization process
PT83119A (en) Process for the preparation of a new class of analogous of vitamin d and of pharmaceutical compounds containing same
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
NO832529L (no) Fremgangsmaate for fremstilling av et topisk anti-inflammatorisk piroxicam-preparat
FI875396A0 (fi) Menetelmä teknetium-99m:llä leimatun elinspesifisen aineen valmistamiseksi
FI892058A0 (fi) Fenolin valmistusmenetelmä
FI885039A (fi) Menetelmät benanomisiinien A ja B sekä deksylosyylibenanomisiinin B valmistamiseksi
FI860101A (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
FI104171B (fi) Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi
FI92396B (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä
DE3660683D1 (en) Process for the preparation of isoxazoles
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
GR80476B (en) Sulfenamide derivatives method for the preparation thereof and medicaments containing said compounds
GB2171408B (en) Mitosane derivative dose preparation
GR860718B (en) Method for the preparation of heterocyclic compounds
EP0232536A3 (en) Spirodiphosphoamidate type compounds and process for their preparation
FI94417B (fi) Menetelmä farmakologisesti aktiivisten aminosteroidien valmistamiseksi
GR861806B (en) Method for the preparation of heterocyclic compounds
PT82334B (en) Process for the preparation of n-(2-phenoxy-ethyl)-nicotinamides and of fungicidal compounds therewith
GR860743B (en) Method for the preparation of imidazo-isochinoline and imidazo-thienopyridin compounds
PT84001B (en) Process for the preparation of new compounds
NO931587D0 (no) Fremgangsmaate for fremstilling av et metylendioksyfenantrenderivat
FI940457A (fi) Menetelmä onkostatiini-A:n valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE LIPOSOME COMPANY, INC.

MA Patent expired